Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For patients:
- You have been told by a doctor that you have a primary malignant brain tumor (a brain tumor that started in the brain, rated on a scale of grades 2 to 4)
- It has been more than 2 weeks since you had brain surgery or a biopsy
- You have reported a higher level of worry or distress about your tumor coming back
- English is your main language
- You are 18 years old or older at the time of joining the trial
For caregivers (family members or friends supporting a patient):
- You are an unpaid, non-professional caregiver for someone who has a primary malignant brain tumor (grades 2 to 4)
- You have reported a higher level of worry or distress about the tumor coming back
- English is your main language
- You are 18 years old or older at the time of joining the trial
Who may not be able to join:
- You have memory or thinking difficulties that might make it hard to fully take part in the program (confirm with trial site)
- You are unable to understand the study information or give your agreement to participate
- You do not have a reliable internet connection, as the sessions are held online
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ashlee R Loughan, Ph.D, Virginia Commonwealth University
Phone: 804-628-6799
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Feasibility - Study Enrollment; Feasibility - Study Retention at 12 Weeks; Feasibility - Study Retention at 24 Weeks; Feasibility - Sustained Eligibility (Delayed Treatment Control Arm Only); Acceptability - Intervention; Acceptability - Intervention; Acceptability - Trial Procedures; Appropriateness - Interventionist Report
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.